Zymar and Vision blurred - a phase IV clinical study of FDA data

Summary:

Vision blurred is reported as a side effect among people who take Zymar (gatifloxacin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lucentis, and have Diabetic retinal oedema.

The phase IV clinical study analyzes which people have Vision blurred when taking Zymar. It is created by eHealthMe based on reports of 672 people who have side effects when taking Zymar from the FDA, and is updated regularly.

What is Zymar?

Zymar has active ingredients of gatifloxacin. eHealthMe is studying from 692 Zymar users. Check the latest studies of Zymar.

What is Vision blurred?

Vision blurred is found to be associated with 2,493 drugs and 2,969 conditions by eHealthMe. Check the latest studies of Vision blurred.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

672 people reported to have side effects when taking Zymar.
Among them, 45 people (6.7%) have Vision blurred.

Among these 45 people:

How long have people been on Zymar when they have Vision blurred? *

What is the gender of people who have Vision blurred when taking Zymar? *

female: 43.18 %
male: 56.82 %

What is the age of people who have Vision blurred when taking Zymar? *

What are other drugs people take besides Zymar? *

What are other side effects people have besides Vision blurred? *

Visual Acuity Reduced (reduced clearness of vision): 14 people, 31.11%
Vitreous Floaters (spots before the eyes): 8 people, 17.78%
Metamorphopsia (a type of distorted vision in which a grid of straight lines appears wavy and parts of the grid may appear blank): 7 people, 15.56%
Cataract (clouding of the lens inside the eye): 6 people, 13.33%
High Blood Pressure: 6 people, 13.33%
Visual Impairment: 6 people, 13.33%
Eye Pain: 6 people, 13.33%
Vitreous Detachment (a condition of the eye in which the vitreous humour separates from the retina): 5 people, 11.11%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 5 people, 11.11%
Blood Glucose Increased: 5 people, 11.11%

What are the existing conditions these people have? *

Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 14 people, 31.11%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 12 people, 26.67%
Retinal Oedema (swelling of retina): 5 people, 11.11%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 4 people, 8.89%
Conjunctivitis (pink eye): 4 people, 8.89%
Heart Rate Irregular: 3 people, 6.67%
Age-Related Macular Degeneration: 2 people, 4.44%
Diabetic Eye Disease: 2 people, 4.44%
Blood Glucose Increased: 2 people, 4.44%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 4.44%

* Approximation only. Some reports may have incomplete information.

Do you take Zymar and have Vision blurred?

- Check whether Vision blurred is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zymar:

Zymar (692 reports)

Vision blurred treatments and more:

Vision blurred (154,118 reports)

Browse all side effects of Zymar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vision blurred:

Vision blurred (2,493 drugs)

Browse all the conditions that are associated with Vision blurred:

Vision blurred (2,969 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gatifloxacin (the active ingredients of Zymar) and Zymar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.